任 庆,田秀荣,王鸿智.介入联合同期放化疗治疗局部晚期鼻咽癌的临床研究[J].肿瘤学杂志,2013,19(3):171-174. |
介入联合同期放化疗治疗局部晚期鼻咽癌的临床研究 |
A Clinical Trial of Transcatheter Superselective Intra-arterial Chemotherapy Combined with Concurrent Chemoradiotherapy in the Treatment for Advanced Nasopharyngeal Carcinoma |
投稿时间:2012-07-30 |
DOI:10.11735/j.issn.1671-170X.2013.03.B2012375 |
|
|
中文关键词: 鼻咽肿瘤 经导管超选择动脉灌注化疗 同期放化疗 |
英文关键词:nasopharyngeal neoplasms transcatheter superselective intra?鄄arterial chemotherapy concurrent chemoradiotherapy |
基金项目: |
|
摘要点击次数: 1804 |
全文下载次数: 1208 |
中文摘要: |
摘 要:[目的] 探讨介入联合同期放化疗治疗局部晚期鼻咽癌的疗效。[方法] 收集108例初治局部晚期鼻咽癌患者(Ⅲ~Ⅳa期),分为介入联合同期放化疗组(研究组)以及同期放化疗组(对照组)。观察并比较两组的近、远期疗效和不良反应。[结果] 研究组与对照组的治疗总有效率分别为92.7%和79.2%,差异有统计学意义(P=0.04)。研究组3年生存率为98.2%,对照组为96.2%;3年复发率分别为9.1%与17.0%,远处转移率分别为5.5%与13.2%,差异均无统计学意义(P>0.05)。两组急性不良反应比较亦无显著性差异。[结论] 介入联合同期放化疗治疗局部晚期鼻咽癌,对比同期放化疗,近期疗效有所提高,急性不良反应相似。 |
英文摘要: |
Abstract:[Purpose] To investigate the effect of transcatheter superselective intra-arterial chemotherapy combined with concurrent chemoradiotherapy in the treatment for advanced nasopharyngeal carcinoma. [Methods] A total of 108 patients with advanced nasopharyngeal carcinoma(stage Ⅲ~Ⅳa) were enrolled in this study,and were divided into transcatheter superselective intra-arterial chemotherapy combined with concurrent chemoradiotherapy group(research group) and concurrent chemoradiotherapy group(control group).The clinical efficacy and side effects were observed and compared between the two groups. [Results] The response rates of research group and control group were 92.7% and 79.2%,respectively,with significant difference(P=0.04). The 3-year survival rates of research group and control group were 98.2% and 96.2%; 3-year local recurrent rates were 9.1% and 17.0%; the distant metastasis rates were 5.5% and 13.2%. None of them had significant difference between two groups. The degree of acute toxicity between two groups was similar,also without significant difference.[Conclusion] Compared with concurrent chemoradiotherapy alone,the selective arterial chemotherapy combined with concurrent chemoradiotherapy is benefit in short-term response in the treatment for advanced nasopharyngeal carcinoma, but the acute toxi-city is similar between the two groups. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |